FI834421A0 - Foerfarande foer framstaellning av 4-aminoalkyl-2(3h)-indoloner - Google Patents

Foerfarande foer framstaellning av 4-aminoalkyl-2(3h)-indoloner

Info

Publication number
FI834421A0
FI834421A0 FI834421A FI834421A FI834421A0 FI 834421 A0 FI834421 A0 FI 834421A0 FI 834421 A FI834421 A FI 834421A FI 834421 A FI834421 A FI 834421A FI 834421 A0 FI834421 A0 FI 834421A0
Authority
FI
Finland
Prior art keywords
indoloner
framstation
aminoalkyl
procedure
Prior art date
Application number
FI834421A
Other languages
English (en)
Other versions
FI77849C (fi
FI77849B (fi
FI834421A (fi
Inventor
Jr Gregory Gallagher
Original Assignee
Smithkline Beckman Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23776840&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FI834421(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Smithkline Beckman Corp filed Critical Smithkline Beckman Corp
Publication of FI834421A0 publication Critical patent/FI834421A0/fi
Publication of FI834421A publication Critical patent/FI834421A/fi
Application granted granted Critical
Publication of FI77849B publication Critical patent/FI77849B/fi
Publication of FI77849C publication Critical patent/FI77849C/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/32—Oxygen atoms
    • C07D209/34—Oxygen atoms in position 2
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/582—Recycling of unreacted starting or intermediate materials

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Indole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
FI834421A 1982-12-07 1983-12-02 Foerfarande foer framstaellning av farmakologiskt aktiva 4-aminoalkyl-2(3h)-indoloner. FI77849C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/447,564 US4452808A (en) 1982-12-07 1982-12-07 4-Aminoalkyl-2(3H)-indolones
US44756482 1982-12-07

Publications (4)

Publication Number Publication Date
FI834421A0 true FI834421A0 (fi) 1983-12-02
FI834421A FI834421A (fi) 1984-06-08
FI77849B FI77849B (fi) 1989-01-31
FI77849C FI77849C (fi) 1989-05-10

Family

ID=23776840

Family Applications (1)

Application Number Title Priority Date Filing Date
FI834421A FI77849C (fi) 1982-12-07 1983-12-02 Foerfarande foer framstaellning av farmakologiskt aktiva 4-aminoalkyl-2(3h)-indoloner.

Country Status (27)

Country Link
US (1) US4452808A (fi)
EP (1) EP0113964B1 (fi)
JP (1) JPS59112964A (fi)
KR (1) KR910001042B1 (fi)
AU (1) AU560170B2 (fi)
BR (1) BR1100036A (fi)
CA (1) CA1208650A (fi)
CY (1) CY1497A (fi)
CZ (1) CZ398191A3 (fi)
DE (1) DE3367090D1 (fi)
DK (1) DK156514C (fi)
DZ (1) DZ587A1 (fi)
EG (1) EG16556A (fi)
ES (2) ES8600239A1 (fi)
FI (1) FI77849C (fi)
GR (1) GR79121B (fi)
HK (1) HK82089A (fi)
IE (1) IE56347B1 (fi)
IL (1) IL70311A (fi)
LU (1) LU90097I2 (fi)
NL (1) NL970005I2 (fi)
NO (2) NO160135C (fi)
NZ (1) NZ206344A (fi)
PH (1) PH22067A (fi)
PT (1) PT77739B (fi)
ZA (1) ZA839094B (fi)
ZW (1) ZW25883A1 (fi)

Families Citing this family (62)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4588740A (en) * 1982-12-07 1986-05-13 Smithkline Beckman Corporation Pharmaceutical methods using 4-aminoalkyl-2(3H)-indolones
US4657929A (en) * 1983-10-25 1987-04-14 Fisons Plc Compounds
US4554284A (en) * 1984-09-12 1985-11-19 Smithkline Beckman Corporation 7-(2-Aminoethyl)-1,3-benzthia- or oxa-zol-2(3H)-ones
GB8621040D0 (en) * 1986-08-30 1986-10-08 Smith Kline French Lab Process
GB8712073D0 (en) * 1987-05-21 1987-06-24 Smith Kline French Lab Medicament
GB8714371D0 (en) * 1987-06-19 1987-07-22 Smith Kline French Lab Process
GB9008605D0 (en) * 1990-04-17 1990-06-13 Smith Kline French Lab Process
GB9015095D0 (en) * 1990-07-09 1990-08-29 Smith Kline French Lab Therapeutic method
IE914003A1 (en) * 1990-11-20 1992-05-20 Astra Pharma Prod Biologically Active Amines
AU4312593A (en) * 1992-05-18 1993-12-13 Smithkline Beecham Plc Use of indolone derivatives for the treatment of memory disorders, sexual dysfunction and Parkinson's disease
GB9300309D0 (en) * 1993-01-08 1993-03-03 Smithkline Beecham Plc Process
TW356468B (en) * 1995-09-15 1999-04-21 Astra Pharma Prod Benzothiazolone compounds useful as beta2-adrenoreceptor and dopamine DA2 receptor agonists process for preparing same and pharmaceutical compositions containing same
US5807570A (en) * 1995-09-29 1998-09-15 Cygnus, Inc. Transdermal administration of ropinirole and analogs thereof
GB9526511D0 (en) * 1995-12-23 1996-02-28 Astra Pharma Prod Pharmaceutically active compounds
JP2000516959A (ja) * 1996-08-27 2000-12-19 アメリカン・ホーム・プロダクツ・コーポレイション ４―アミノエトキシインドロン誘導体
ZA992670B (en) * 1998-04-13 2000-10-12 American Home Prod 4-amino-(ethylamino)-oxindole dopamine autoreceptor agonists.
US6218421B1 (en) * 1999-07-01 2001-04-17 Smithkline Beecham P.L.C. Method of promoting smoking cessation
AR030557A1 (es) 2000-04-14 2003-08-27 Jagotec Ag Una tableta en multicapa de liberacion controlada y metodo de tratamiento
US6277875B1 (en) * 2000-07-17 2001-08-21 Andrew J. Holman Use of dopamine D2/D3 receptor agonists to treat fibromyalgia
DE10041478A1 (de) * 2000-08-24 2002-03-14 Sanol Arznei Schwarz Gmbh Neue pharmazeutische Zusammensetzung
US20020165246A1 (en) * 2001-03-05 2002-11-07 Andrew Holman Administration of sleep restorative agents
FR2821843B1 (fr) * 2001-03-12 2003-05-09 Servier Lab Nouveaux derives d'isoindoloindolones, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
US20030068356A1 (en) * 2001-07-10 2003-04-10 Pather S. Indiran Sequential drug delivery systems
DK1545546T3 (da) * 2002-09-13 2007-08-06 Motac Neuroscience Ltd Behandling af dyskinesi med 2,3-benzodiazepiner
AU2003267557B2 (en) * 2002-09-17 2009-02-26 Motac Neuroscience Limited Treatment of dyskinesia
ES2237307B1 (es) * 2003-10-14 2006-11-01 Urquima, S.A. Procedimiento para la preparacion de ropinirol.
WO2005074387A2 (en) * 2003-12-30 2005-08-18 Sun Pharmaceutical Industries Limited Novel crystal forms of 4-[2-di-n-propylamino)ethyl]-2 (3h)- indolone hydrochloride
US7378439B2 (en) * 2004-01-20 2008-05-27 Usv, Ltd. Process for the preparation of 4-(2-dipropylaminoethyl)-1,3-dihydro-2H-indol-2-one hydrochloride
WO2005105741A1 (en) * 2004-02-11 2005-11-10 Sun Pharmaceutical Industries Limited Substantially pure 4-[2-(di-n-propylamino)ethyl]-2(3h)-indolone hydrochloride
WO2005080333A1 (en) * 2004-02-19 2005-09-01 Torrent Pharmaceuticals Ltd Process for purification of ropinirole
RS20060620A (en) * 2004-05-11 2008-09-29 Egis Gyogyszergyar Nyrt., Piperazine derivatives of alkyl oxindoles
HUP0400953A3 (en) * 2004-05-11 2008-02-28 Egis Gyogyszergyar Nyilvanosan Piperazine derivatives of alkyl-oxindoles, pharmaceutical compositions containing them, process for producing them and their use
US20050267096A1 (en) * 2004-05-26 2005-12-01 Pfizer Inc New indazole and indolone derivatives and their use pharmaceuticals
US20050288270A1 (en) * 2004-05-27 2005-12-29 Pfizer Inc New aminopyridine derivatives and their use as pharmaceuticals
JP2008533193A (ja) * 2005-03-21 2008-08-21 ファイザー・リミテッド オキシトシン拮抗薬としての置換トリアゾール誘導体
CN100457711C (zh) * 2005-06-27 2009-02-04 上海奥博生物医药技术有限公司 2-甲基-3-硝基苯基烷基胺衍生物或其盐的制备方法
WO2007010557A2 (en) * 2005-07-22 2007-01-25 Ind-Swift Laboratorie Limted Process for the preparation of highly pure ropinirole
WO2007110879A2 (en) 2006-03-29 2007-10-04 Alembic Limited A process for the purification of ropinirole hydrochloride
DK2010184T3 (da) * 2006-04-06 2013-03-25 Nupathe Inc Implatanter til behandlingen af dopamin associerede tilstande
US20070254941A1 (en) * 2006-04-21 2007-11-01 Glenmark Pharmaceuticals Limited Subtantially pure ropinirole hydrochloride, polymorphic form of ropinirole and process for their preparation
CN100457732C (zh) * 2006-05-25 2009-02-04 药源药物化学（上海）有限公司 罗匹尼罗的制备方法
WO2008001204A2 (en) * 2006-06-29 2008-01-03 Antares Pharma Ipl Ag Transdermal compositions of pramipexole having enhanced permeation properties
TW200815045A (en) * 2006-06-29 2008-04-01 Jazz Pharmaceuticals Inc Pharmaceutical compositions of ropinirole and methods of use thereof
JP2008308488A (ja) * 2007-05-11 2008-12-25 Santen Pharmaceut Co Ltd 非麦角系の選択的ｄ２受容体アゴニストを有効成分として含有する後眼部疾患の予防又は治療剤
US20090076124A1 (en) * 2007-09-14 2009-03-19 Protia, Llc Deuterium-enriched ropinirole
US20090247537A1 (en) * 2008-03-25 2009-10-01 William Dale Overfield Methods for preventing or treating bruxism using dopaminergic agents
CN101574341B (zh) * 2008-05-05 2012-12-19 北京德众万全医药科技有限公司 一种罗匹尼罗的口服固体药物组合物
WO2010023693A2 (en) * 2008-09-01 2010-03-04 Lupin Limited Novel controlled release compositions of ropinirole
CA2738414C (en) 2008-09-29 2014-05-27 Wockhardt Research Centre Extended release dosage form of ropinirole
US20100130582A1 (en) * 2008-11-24 2010-05-27 Auspex Pharmaceuticals, Inc. Indolinone modulators of dopamine receptor
EP2438917B1 (en) 2009-05-21 2014-09-03 Hisamitsu Pharmaceutical Co., Inc. Transdermal preparation
AU2009356855A1 (en) * 2009-12-16 2012-08-09 Pharmathen S.A. Process for the preparation of Ropinirole and salts thereof
EA023786B1 (ru) 2010-04-30 2016-07-29 ТЕЙКОКУ ФАРМА ЮЭсЭй, ИНК. Трансдермальные композиции на основе пропиниламиноиндана
CN101891641B (zh) * 2010-07-27 2015-06-10 北京华禧联合科技发展有限公司 盐酸罗匹尼罗关键中间体的稳定形态及其制备
TWI537274B (zh) 2011-03-14 2016-06-11 橘生藥品工業股份有限公司 新穎之八氫噻吩并喹啉衍生物、含有其之醫藥組成物及該等之用途
EP2688561B1 (en) 2011-03-24 2018-08-22 Teikoku Pharma USA, Inc. Transdermal compositions comprising an active agent layer and an active agent conversion layer
US9913812B2 (en) 2011-11-09 2018-03-13 Teikoku Pharma Usa, Inc. Methods for the treatment of skin neoplasms
JP6050896B2 (ja) 2012-11-02 2016-12-21 テイコク ファーマ ユーエスエー インコーポレーテッド プロピニルアミノインダン経皮組成物
US9585885B2 (en) 2012-12-10 2017-03-07 Kissei Pharmaceutical Co., Ltd. Substituted pyrido[2,3-g]quinazolines as dopamine D2 receptor agonists
US9155695B2 (en) 2013-03-14 2015-10-13 Medtronic, Inc. Injectable ropinirole compositions and methods for making and using same
EP3640240B1 (en) 2017-06-16 2020-12-09 Zhejiang Huahai Licheng Pharmaceutical Co., Ltd. Method for purifying ropinirole hydrochloride
CN115466209A (zh) * 2022-09-29 2022-12-13 南通大学 一种罗匹尼罗环戊烷并吲哚酮杂质的合成方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA895875A (en) * 1972-03-21 Bourdais Jacques Mercapto indole derivatives
US3573310A (en) * 1967-09-28 1971-03-30 Miles Lab 1-substituted derivatives of 2-indolinone
JPS5825673B2 (ja) * 1976-03-31 1983-05-28 大塚製薬株式会社 オキシインド−ル誘導体
JPS5840539B2 (ja) * 1976-03-31 1983-09-06 大塚製薬株式会社 α−置換アミノアルカノイルオキシインド−ル誘導体
JPS5919537B2 (ja) * 1976-08-02 1984-05-07 大塚製薬株式会社 オキシインド−ル誘導体
US4317944A (en) * 1980-08-15 1982-03-02 General Electric Company Preparation of 2,2-bis(4-hydroxyphenyl) propane
US4314944A (en) * 1980-08-22 1982-02-09 Smithkline Corporation 4-Aminoalkyl-7-hydroxy-2(3H)-indolones

Also Published As

Publication number Publication date
ES527827A0 (es) 1985-10-01
IE56347B1 (en) 1991-07-03
JPH0150703B2 (fi) 1989-10-31
IE832866L (en) 1984-06-07
DE3367090D1 (de) 1986-11-27
US4452808A (en) 1984-06-05
FI77849C (fi) 1989-05-10
DK156514C (da) 1990-03-12
EP0113964B1 (en) 1986-10-22
PT77739A (en) 1983-12-01
NO160135B (no) 1988-12-05
DK156514B (da) 1989-09-04
ES8604143A1 (es) 1986-01-16
PT77739B (en) 1986-03-27
JPS59112964A (ja) 1984-06-29
NL970005I1 (nl) 1997-04-01
NL970005I2 (nl) 1997-10-01
BR1100036A (pt) 2000-01-11
KR910001042B1 (ko) 1991-02-21
NO1999011I1 (no) 1999-06-18
CZ398191A3 (en) 1993-02-17
NO834485L (no) 1984-06-08
NO160135C (no) 1989-03-15
CA1208650A (en) 1986-07-29
ZA839094B (en) 1985-02-27
ES543593A0 (es) 1986-01-16
DZ587A1 (fr) 2004-09-13
CY1497A (en) 1990-02-16
EP0113964A1 (en) 1984-07-25
GR79121B (fi) 1984-10-02
NZ206344A (en) 1987-03-31
AU560170B2 (en) 1987-04-02
KR840006963A (ko) 1984-12-04
DK562183A (da) 1984-06-08
PH22067A (en) 1988-05-20
AU2158583A (en) 1984-06-14
ZW25883A1 (en) 1984-04-18
FI77849B (fi) 1989-01-31
LU90097I2 (fr) 1997-07-16
DK562183D0 (da) 1983-12-06
IL70311A (en) 1986-11-30
EG16556A (en) 1989-01-30
FI834421A (fi) 1984-06-08
IL70311A0 (en) 1984-02-29
ES8600239A1 (es) 1985-10-01
HK82089A (en) 1989-10-20

Similar Documents

Publication Publication Date Title
FI834421A0 (fi) Foerfarande foer framstaellning av 4-aminoalkyl-2(3h)-indoloner
FI834498A0 (fi) Foerfarande foer diffusionssvetsning
ES524096A0 (es) Nuevos derivados de 19-tioandrostano
FI831148A0 (fi) Foerfarande foer framstaellning av substituerade penemderivat
NO833531L (no) Fremgangsmaate for fremstilling av 7-substituerte-3-vinyl-3-cefem-forbindelser
FI833648A0 (fi) Foerfarande foer framstaellning av 4-metyl-5-alkyltiometylimidazoler
RO88128A (ro) Procedeu pentru prepararea n-fosfanometilglicinei
FI832790A0 (fi) Regleringsanordning foer oeppningen i en ljusbaoge foer glassmaeltningsugn
FI833868A0 (fi) Anordning foer daempning av en slagbelastning
FI832919A0 (fi) Foerfarande foer framstaellning av n-substituerad nikotinamid-1-oxid och dess salter
SE8207343L (sv) Forfarande for omkristallisation av gips
FI830807L (fi) Anordning foer utnyttjande av vattnets vaogroerelse
FI813798L (fi) Foerfarande foer avlaegsnande av en belaeggning av antrakinon
FI811638A0 (fi) Foerfarande foer framstaellning av en terapeutiskt vaerdefull heterocyklisk foerening
FI823921A0 (fi) Foerfarande foer framstaellning av parakinon- eller ortokinonderivat
TR21803A (tr) Atese dayanikh krommagnezi ueruenlerinin ueretilmesine mahsus usul
FI832578A0 (fi) Foerfarande foer framstaellning av en hydroliserbar titanylsulfatloesning
RO85310A7 (ro) Procedeu de microincapsulare
FI830451A0 (fi) Foerfarande foer framstaellning av 1-substituerade 6-n-propyl-8-metyl-imidazo /1,5-d/-as-triazin-4 (3h)oner
RO80866A2 (ro) Procedeu pentru cateterizarea venelor
BR6201205U (pt) Conjunto de marmitas
FI833009A (fi) Foerfarande foer framstaellning av en immobiliserad glukoamylasenzymsammansaettning
FI831058L (fi) Anordning foer fokuserad anvaendning av solstraolar
SE8303428D0 (sv) Forfarande av delignifiering av cellulosamassa
FI822449A0 (fi) Skopa foer roejning av skogsdikar

Legal Events

Date Code Title Description
SPCG Supplementary protection certificate granted

Spc suppl protection certif: L182

Extension date: 20081201

MA Patent expired

Owner name: SMITHKLINE BEECHAM CORPORATION